Sen. Christine Radogno

Filed: 3/1/2017

 

 


 

 


 
10000SB0012sam003LRB100 06318 JLS 22687 a

1
AMENDMENT TO SENATE BILL 12

2    AMENDMENT NO. ______. Amend Senate Bill 12 on page 10, line
323, by deleting "1,"; and
 
4on page 10, line 23, by deleting "8.7,"; and
 
5on page 10, line 24, by changing "14.3" to "29.3"; and
 
6by deleting all of pages 11 through 18; and
 
7on page 19, by deleting lines 1 through 15; and
 
8on page 26, by replacing lines 1 and 2 with the following:
9"lasts more than 5 scheduled 3 working days for the claimant,
10weekly compensation as hereinafter provided shall be paid
11beginning on the 6th 4th day"; and
 
12on page 29, line 20, by changing "$755.22" to "$775.18"; and
 

 

 

10000SB0012sam003- 2 -LRB100 06318 JLS 22687 a

1on page 45, by replacing lines 16 and 17 with the following:
2"fingers, leg, foot, or any toes, or loss under Section 8(d)2
3due to accidental injuries to the same part of the spine, such
4loss or partial loss of any such member or loss under Section
58(d)2 due to accidental injuries to the same part of the spine
6shall be deducted from any award made"; and
 
7on page 45, line 20, by replacing "eye" with "eye or loss under
8Section 8(d)2 due to accidental injuries to the same part of
9the spine"; and
 
10on page 45, line 22, by inserting immediately following the
11period the following:
12"For purposes of this subdivision (e)17 only, "same part of the
13spine" means: (1) cervical spine and thoracic spine from
14vertebra C1 through T12 and (2) lumbar and sacral spine and
15coccyx from vertebra L1 through S5."; and
 
16on page 46, by replacing lines 6 through 21 with the following:
17"members, and in a subsequent independent accident loses
18another or suffers the permanent and complete loss of the use
19of any one of such members the employer for whom the injured
20employee is working at the time of the last independent
21accident is liable to pay compensation only for the loss or
22permanent and complete loss of the use of the member occasioned

 

 

10000SB0012sam003- 3 -LRB100 06318 JLS 22687 a

1by the last independent accident."; and
 
2by replacing lines 15 through 25 of page 57 and lines 1 through
322 of page 58 with the following:
4    "(a) A physician licensed to practice medicine in all of
5its branches preparing a permanent partial disability
6impairment report shall report the level of impairment in
7writing. The report shall include an evaluation of medically
8defined and professionally appropriate measurements of
9impairment that include, but are not limited to: loss of range
10of motion; loss of strength; measured atrophy of tissue mass
11consistent with the injury; and any other measurements that
12establish the nature and extent of the impairment. The most
13current edition of the American Medical Association's "Guides
14to the Evaluation of Permanent Impairment" shall be used by the
15physician in determining the level of impairment. A report
16under this subsection may be waived by joint written agreement
17of the parties.
18    (b) Where an impairment report pursuant to subsection (a)
19exists, it must be considered by the Commission in its
20determination of the level of permanent partial disability.
21    In determining the level of permanent partial disability,
22the Commission shall base its determination on the reported
23level of impairment pursuant to subsection (a). In addition to
24any impairment report submitted, the Commission may, by a
25preponderance of credible evidence, use the following

 

 

10000SB0012sam003- 4 -LRB100 06318 JLS 22687 a

1additional factors to determine disability: (i) the occupation
2of the injured employee; (ii) the age of the employee at the
3time of the injury; (iii) the employee's future earning
4capacity; and (iv) evidence of disability at maximum medical
5improvement corroborated by objective findings in the treating
6medical records and independent medical exams. In determining
7the level of permanent partial disability, the Commission may
8base its determination on a report of impairment, after
9considering by a preponderance of credible evidence, the
10additional factors to determine disability.
11    (c) A report of impairment prepared pursuant to subsection
12(a) is not required for the arbitrator or Commission to approve
13a Settlement Contract Lump Sum Petition.
14    (b) In determining the level of permanent partial
15disability, the Commission shall base its determination on the
16following factors: (i) the reported level of impairment
17pursuant to subsection (a); (ii) the occupation of the injured
18employee; (iii) the age of the employee at the time of the
19injury; (iv) the employee's future earning capacity; and (v)
20evidence of disability corroborated by the treating medical
21records. No single enumerated factor shall be the sole
22determinant of disability. In determining the level of
23disability, the relevance and weight of any factors used in
24addition to the level of impairment as reported by the
25physician must be explained in a written order."; and
 

 

 

10000SB0012sam003- 5 -LRB100 06318 JLS 22687 a

1on page 61, by inserting after line 7 the following:
2    The provisions of this subsection (a), other than this
3sentence, are inoperative after August 31, 2017.
 
4on page 64, by inserting after line 18 the following:
5    The provisions of this subsection (a-1), other than this
6sentence, are inoperative after August 31, 2017.
7    (a-1.5) The following provisions apply to procedures,
8treatments, services, products, and supplies covered under
9this Act and rendered or to be rendered on or after September
101, 2017:
11        (1) In this Section:
12        "CPT code" means each Current Procedural Terminology
13    code, for each geographic region specified in subsection
14    (b) of this Section, included on the most recent medical
15    fee schedule established by the Commission pursuant to this
16    Section.
17        "DRG code" means each current diagnosis related group
18    code, for each geographic region specified in subsection
19    (b) of this Section, included on the most recent medical
20    fee schedule established by the Commission pursuant to this
21    Section.
22        "Geozip" means a three-digit zip code based on data
23    similarities, geographical similarities, and frequencies.
24        "Health care services" means those CPT and DRG codes
25    for procedures, treatments, products, services or supplies

 

 

10000SB0012sam003- 6 -LRB100 06318 JLS 22687 a

1    for hospital inpatient, hospital outpatient, emergency
2    room, ambulatory surgical treatment centers, accredited
3    ambulatory surgical treatment facilities, and professional
4    services. It does not include codes classified as
5    healthcare common procedure coding systems or dental.
6        "Medicare maximum fee" means, for each CPT and DRG
7    code, the current maximum fee for that CPT or DRG code
8    allowed to be charged by the Centers for Medicare and
9    Medicaid Services for Medicare patients in that geographic
10    region. The Medicare maximum fee shall be the greater of
11    (i) the current maximum fee allowed to be charged by the
12    Centers for Medicare and Medicaid Services for Medicare
13    patients in the geographic region or (ii) the maximum fee
14    charged by the Centers for Medicare and Medicaid Services
15    for Medicare patients in the geographic region on January
16    1, 2017.
17        "Medicare percentage amount" means, for each CPT and
18    DRG code, the workers' compensation maximum fee as a
19    percentage of the Medicare maximum fee.
20        "Workers' compensation maximum fee" means, for each
21    CPT and DRG code, the current maximum fee allowed to be
22    charged under the medical fee schedule established by the
23    Commission for that CPT or DRG code in that geographic
24    region.
25        (2) The Commission shall establish and maintain fee
26    schedules for procedures, treatments, products, services,

 

 

10000SB0012sam003- 7 -LRB100 06318 JLS 22687 a

1    or supplies for hospital inpatient, hospital outpatient,
2    emergency room, ambulatory surgical treatment centers,
3    accredited ambulatory surgical treatment facilities,
4    prescriptions filled and dispensed outside of a licensed
5    pharmacy, dental services, and professional services.
6    These fee schedule amounts shall be grouped into geographic
7    regions in the following manner:
8            (A) Four regions for non-hospital fee schedule
9        amounts shall be utilized:
10                (i) Cook County;
11                (ii) DuPage, Kane, Lake, and Will Counties;
12                (iii) Bond, Calhoun, Clinton, Jersey,
13            Macoupin, Madison, Monroe, Montgomery, Randolph,
14            St. Clair, and Washington Counties; and
15                (iv) All other counties of the State.
16            (B) Fourteen regions for hospital fee schedule
17        amounts shall be utilized:
18                (i) Cook, DuPage, Will, Kane, McHenry, DeKalb,
19            Kendall, and Grundy Counties;
20                (ii) Kankakee County;
21                (iii) Madison, St. Clair, Macoupin, Clinton,
22            Monroe, Jersey, Bond, and Calhoun Counties;
23                (iv) Winnebago and Boone Counties;
24                (v) Peoria, Tazewell, Woodford, Marshall, and
25            Stark Counties;
26                (vi) Champaign, Piatt, and Ford Counties;

 

 

10000SB0012sam003- 8 -LRB100 06318 JLS 22687 a

1                (vii) Rock Island, Henry, and Mercer Counties;
2                (viii) Sangamon and Menard Counties;
3                (ix) McLean County;
4                (x) Lake County;
5                (xi) Macon County;
6                (xii) Vermilion County;
7                (xiii) Alexander County; and
8                (xiv) All other counties of the State.
9        If a geozip overlaps into one or more of the regions
10    set forth in this Section, then the Commission shall
11    average or repeat the charges and fees in a geozip in order
12    to designate charges and fees for each region.
13        (3) The initial workers' compensation maximum fee for
14    each CPT and DRG code as of September 1, 2017 shall be
15    determined as follows:
16            (A) Within 45 days after the effective date of this
17        amendatory Act of the 100th General Assembly, the
18        Commission shall determine the Medicare percentage
19        amount for each CPT and DRG code using the most recent
20        data available.
21            CPT or DRG codes which have a value, but are not
22        covered expenses under Medicare, are still compensable
23        under the medical fee schedule according to the rate
24        described in Section (B).
25            (B) Within 30 days after the Commission makes the
26        determinations required by subdivision (3)(A) of this

 

 

10000SB0012sam003- 9 -LRB100 06318 JLS 22687 a

1        subsection (a-1.5), the Commission shall determine an
2        adjustment to be made to the workers' compensation
3        maximum fee for each CPT and DRG code as follows:
4                (i) If the Medicare percentage amount for that
5            CPT or DRG code is equal to or less than 125%, then
6            the workers' compensation maximum fee for that CPT
7            or DRG code shall be adjusted so that it equals
8            125% the most recent Medicare maximum fee for that
9            CPT or DRG code.
10                (ii) If the Medicare percentage amount for
11            that CPT or DRG code is greater than 125% but less
12            than 150%, then the workers' compensation maximum
13            fee for that CPT or DRG code shall not be adjusted.
14                (iii) If the Medicare percentage amount for
15            that CPT or DRG code is greater than 150% but less
16            than or equal to 225%, then the workers'
17            compensation maximum fee for that CPT or DRG code
18            shall be adjusted so that it equals the greater of
19            (I) 150% of the most recent Medicare maximum fee
20            for that CPT or DRG code or (II) 80% of the most
21            recent workers' compensation maximum amount for
22            that CPT or DRG code.
23                (iv) If the Medicare percentage amount for
24            that CPT or DRG code is greater than 225% but less
25            than or equal to 428.57%, then the workers'
26            compensation maximum fee for that CPT or DRG code

 

 

10000SB0012sam003- 10 -LRB100 06318 JLS 22687 a

1            shall be adjusted so that it equals the greater of
2            (I) 191.25% of the most recent Medicare maximum fee
3            for that CPT or DRG code or (II) 70% of the most
4            recent workers' compensation maximum amount for
5            that CPT or DRG code.
6                (v) If the Medicare percentage amount for that
7            CPT or DRG code is greater than 428.57%, then the
8            workers' compensation maximum fee for that CPT or
9            DRG code shall be adjusted so that it equals 275%
10            of the most recent Medicare maximum fee for that
11            CPT or DRG code.
12            The Commission shall promptly publish the
13        adjustments determined pursuant to this subdivision
14        (3)(B) on its website.
15            (C) The initial workers' compensation maximum fee
16        for each CPT and DRG code as of September 1, 2017 shall
17        be equal to the workers' compensation maximum fee for
18        that code as determined and adjusted pursuant to
19        subdivision (3)(B) of this subsection, subject to any
20        further adjustments pursuant to subdivision (5) of
21        this subsection.
22        (4) The Commission, as of September 1, 2018 and
23    September 1 of each year thereafter, shall adjust the
24    workers' compensation maximum fee for each CPT or DRG code
25    to exactly half of the most recent annual increase in the
26    Consumer Price Index-U.

 

 

10000SB0012sam003- 11 -LRB100 06318 JLS 22687 a

1        (5) A person who believes that the workers'
2    compensation maximum fee for a CPT or DRG code, as
3    otherwise determined pursuant to this subsection, creates
4    or would create upon implementation a significant
5    limitation on access to quality health care in either a
6    specific field of health care services or a specific
7    geographic limitation on access to health care may petition
8    the Commission to modify the workers' compensation maximum
9    fee for that CPT or DRG code so as to not create that
10    significant limitation.
11        The petitioner bears the burden of demonstrating, by a
12    preponderance of the credible evidence, that the workers'
13    compensation maximum fee that would otherwise apply would
14    create a significant limitation on access to quality health
15    care in either a specific field of health care services or
16    a specific geographic limitation on access to health care.
17    Petitions shall be made publicly available. Such credible
18    evidence shall include empirical data demonstrating a
19    significant limitation on access to quality health care.
20    Other interested persons may file comments or responses to
21    a petition within 30 days of the filing of a petition.
22        The Commission shall take final action on each petition
23    within 180 days of filing. The Commission may, but is not
24    required to, seek the recommendation of the Medical Fee
25    Advisory Board to assist with this determination. If the
26    Commission grants the petition, the Commission shall

 

 

10000SB0012sam003- 12 -LRB100 06318 JLS 22687 a

1    further increase the workers' compensation maximum fee for
2    that CPT or DRG code by the amount minimally necessary to
3    avoid creating a significant limitation on access to
4    quality health care in either a specific field of health
5    care services or a specific geographic limitation on access
6    to health care. The increased workers' compensation
7    maximum fee shall take effect upon entry of the
8    Commission's final action."; and
 
9on page 64, line 24, by inserting after the period the
10following:
11The provisions of this subsection (a-2), other than this
12sentence, are inoperative after August 31, 2017.
 
13by deleting lines 25 and 26 of page 64 and all of page 65; and
 
14on page 66, by replacing lines 1 through 15 with the following:
15    "(a-3) Prescriptions, other than custom compound
16medications, filled and dispensed outside of a licensed
17pharmacy shall be subject to a fee schedule that shall not
18exceed the Average Wholesale Price (AWP) plus a dispensing fee
19of $4.18. AWP or its equivalent as registered by the National
20Drug Code shall be set forth for that drug on that date as
21published in Medi-Span. Custom compound medications are
22governed by subsection (a-4).
23    (a-4) As used in this Section:

 

 

10000SB0012sam003- 13 -LRB100 06318 JLS 22687 a

1    "Custom compound medication" means a customized medication
2prescribed or ordered by a duly licensed prescriber for the
3specific patient that is prepared in a pharmacy by a licensed
4pharmacist in response to a licensed prescriber's prescription
5or order by combining, mixing, or altering of ingredients, but
6not reconstituting, to meet the unique needs of an individual
7patient. A custom compound medication does not include a drug
8reconstituted pursuant to a manufacturer's direction nor does
9it include the sole act of tablet splitting or crushing,
10capsule opening, or the addition of a flavoring agent to
11enhance palatability.
12    A custom compound medication shall be approved for payment
13only if the custom compound medication meets all of the
14following standards:
15        (1) there is no readily available commercially
16    manufactured therapeutically equivalent product;
17        (2) no other Food and Drug Administration-approved
18    alternative drug or combination of readily available drugs
19    is appropriate for the patient;
20        (3) the active ingredients of the custom compound
21    medication each have a National Drug Code (NDC) number, are
22    components of drugs approved by the Food and Drug
23    Administration, and the active ingredients in the custom
24    compound medication are being used to treat conditions for
25    which the component drugs have been approved for use by the
26    Food and Drug Administration;

 

 

10000SB0012sam003- 14 -LRB100 06318 JLS 22687 a

1        (4) no component of the custom compound medication has
2    been withdrawn or removed from the market for safety
3    reasons; and
4        (5) the prescriber is able to demonstrate to the payer
5    that the custom compound medication is reasonable and
6    necessary.
7    The Average Wholesale Price (AWP) for the specific amount
8of each component, as identified by its National Drug Code
9(NDC) from the original labeler, shall be used to determine the
10maximum reimbursement of a custom compound medication meeting
11the standards of subsection (a-5). A single dispensing fee for
12a custom compound medication shall be based on the actual costs
13of preparing and dispensing the custom compound medication as
14determined by the Commission. The dispensing fee for a custom
15compound medication shall be billed with code WC 700-C.
16    This Section is subject to the other provisions of this Act
17including, but not limited to, Section 8.7.
18    The changes to this Section made by this amendatory Act of
19the 100th General Assembly apply to compounding medications
20provided on or after the effective date of this amendatory Act
21of the 100th General Assembly.
22    (a-5) Notwithstanding any other provision of this Section,
23on or before March 1, 2018 and on or before March 1 of each
24subsequent year, the Commission must investigate all
25procedures, treatments, and services covered under this Act for
26ambulatory surgical treatment centers and accredited

 

 

10000SB0012sam003- 15 -LRB100 06318 JLS 22687 a

1ambulatory surgical treatment facilities and establish fee
2schedule amounts for procedures, treatments, and services for
3which fee schedule amounts have not been established. The
4Commission must adopt, in a timely and ongoing manner, all
5rules necessary to ensure that its responsibilities under this
6subsection are carried out.
7    (a-3) Prescriptions filled and dispensed outside of a
8licensed pharmacy shall be subject to a fee schedule that shall
9not exceed the Average Wholesale Price (AWP) plus a dispensing
10fee of $4.18. AWP or its equivalent as registered by the
11National Drug Code shall be set forth for that drug on that
12date as published in Medispan."; and
 
13by deleting lines 22 through 25 of page 73, all of pages 74
14through 80, and lines 1 through 12 of page 81; and
 
15by deleting lines 18 through 25 of page 86, all of pages 87 and
1688, and lines 1 through 7 of page 89; and
 
17by replacing lines 20 through 26 of page 92 and lines 1 through
1823 of page 93 with the following:
19    "Whether the employee is working or not, if the employee is
20not receiving or has not received medical, surgical, or
21hospital services or other services or compensation as provided
22in paragraph (a) of Section 8, or compensation as provided in
23paragraph (b) of Section 8, or if the employer has refused or

 

 

10000SB0012sam003- 16 -LRB100 06318 JLS 22687 a

1failed to respond to a written request for authorization of
2medical care and treatment, the employee may at any time
3petition for an expedited hearing by an Arbitrator on the issue
4of whether or not he or she is entitled to receive payment of
5the services or compensation or authorization of medical care.
6Provided the employer continues to pay compensation pursuant to
7paragraph (b) of Section 8, the employer may at any time
8petition for an expedited hearing on the issue of whether or
9not the employee is entitled to receive medical, surgical, or
10hospital services or other services or compensation as provided
11in paragraph (a) of Section 8, whether or not the employee is
12entitled to authorization of medical care and treatment, or
13compensation as provided in paragraph (b) of Section 8. When an
14employer has petitioned for an expedited hearing, the employer
15shall continue to pay compensation as provided in paragraph (b)
16of Section 8 unless the arbitrator renders a decision that the
17employee is not entitled to the benefits that are the subject
18of the expedited hearing or unless the employee's treating
19physician has released the employee to return to work at his or
20her regular job with the employer or the employee actually
21returns to work at any other job. If the arbitrator renders a
22decision that the employee is not entitled to the benefits or
23medical care that is are the subject of the expedited hearing,
24a petition for review filed by the employee shall receive the
25same priority as if the employee had filed a petition for an
26expedited hearing by an Arbitrator. Neither party shall be

 

 

10000SB0012sam003- 17 -LRB100 06318 JLS 22687 a

1entitled to an expedited hearing when the employee has returned
2to work and the sole issue in dispute amounts to less than 12
3weeks of unpaid compensation pursuant to paragraph (b) of
4Section 8."; and
 
5on page 113, by replacing lines 7 through 18 with the
6following:
7    "(k) In a case where there has been any unreasonable or
8vexatious delay of payment or intentional underpayment of
9compensation, or proceedings have been instituted or carried on
10by the one liable to pay the compensation, which do not present
11a real controversy, but are merely frivolous or for delay, then
12the Commission may award compensation additional to that
13otherwise payable under this Act equal to 50% of the amount
14payable at the time of such award. Failure to pay compensation
15in accordance with the provisions of Section 8, paragraph (b)
16of this Act, shall be considered unreasonable delay."; and
 
17on page 131, by deleting lines 23 and 24; and
 
18on page 131, line 25, by changing "(6)" to "(5)"; and
 
19on page 132, line 2, by changing "(7)" to "(6)"; and
 
20on page 132, line 12, by changing "(8)" to "(7)"; and
 

 

 

10000SB0012sam003- 18 -LRB100 06318 JLS 22687 a

1on page 134, by replacing lines 14 through 17 with the
2following:
 
3    "(820 ILCS 305/29.3 new)
4    Sec. 29.3. Workers' Compensation Transparency Task Force.
5    (a) There is created the Workers' Compensation
6Transparency Task Force consisting of the following members:
7        (1) The Director of Insurance or his or her designee.
8        (2) The Chairman of the Illinois Workers' Compensation
9    Commission or his or her designee.
10        (3) One member of the House of Representatives
11    appointed by the Speaker of the House of Representatives.
12        (4) One member of the House of Representatives
13    appointed by the Minority Leader of the House of
14    Representatives.
15        (5) One member of the Senate appointed by the President
16    of the Senate.
17        (6) One member of the Senate appointed by the Minority
18    Leader of the Senate.
19    (b) The Task Force shall collect and review information and
20data on the effects of the changes in workers' compensation law
21enacted by the General Assembly. The purpose of the collection
22and review of information under this Section is to make as
23transparent as possible all information relating to the medical
24treatment and benefits paid to injured workers in this State.
25    (c) In order to enable the Task Force to complete its

 

 

10000SB0012sam003- 19 -LRB100 06318 JLS 22687 a

1purpose, insurers, advisory organizations, and medical
2providers involved in the provision of services to persons
3covered under the workers' compensation laws of this State
4shall report data and information to the Task Force on an
5annual basis.
6    (d) Insurers and advisory organizations shall report to the
7Task Force the information required to be reported under
8Section 29.2.
9    (e) Medical providers shall report workers' compensation
10information including, but not limited to, the following:
11        (1) Gross revenue attributable to workers'
12    compensation care of injured workers.
13        (2) Expenses incurred in the medical treatment of
14    injured workers.
15        (3) The number of patients treated with respect to
16    workers' compensation claims.
17        (4) The time and resources expended on the medical
18    treatment of injured workers.
19        (5) Complaints registered with the licensing authority
20    for medical providers related to the treatment of injured
21    workers relating to the workers' compensation laws.
22        (6) Profits made as a result of the medical treatment
23    provided to injured workers.
24        (7) Any additional information that is determined by
25    the Task Force to be necessary for the effective analysis
26    of the effect of changes in workers' compensation laws.

 

 

10000SB0012sam003- 20 -LRB100 06318 JLS 22687 a

1    (f) The Task Force shall report its findings to the
2Governor and General Assembly by March 31 of each year. The
3findings in the report shall be based upon the information
4reported to the Task Force by December 31 of the year preceding
5the date of the report.
6    (g) The Task Force shall end its collection of information
7on December 31, 2021 and issue its final report no later than
8March 31, 2022.
9    (h) A person or entity that fails to comply with the
10reporting requirements of this Section is subject to a civil
11penalty of $100 per day for each category of information
12required to be reported up to a maximum of $10,000. The
13Attorney General may bring an action to enforce the penalty
14authorized under this subsection. If a person or entity incurs
15more than $10,000 in penalties under this subsection, the
16license of the person or entity may be suspended.
17    (i) This Section is repealed on January 1, 2022.
 
18    Section 99. Effective date. This Act takes effect upon
19becoming law, but this Act does not take effect at all unless
20Senate Bills 1, 3, 4, 5, 6, 7, 8, 9, 10, 13, and 16 of the 100th
21General Assembly become law.".